香港股市 已收市

Merck & Co., Inc. (MRK)

NYSE - NYSE 延遲價格。貨幣為 USD。
加入追蹤清單
91.89-2.52 (-2.67%)
收市價: 04:03PM EDT
91.94 +0.05 (+0.05%)
市前: 04:07AM EDT
全螢幕
交易股價資料並非來自所有市場
前收市價94.41
開市94.11
買盤91.37 x 900
賣出價92.27 x 800
今日波幅91.47 - 94.33
52 週波幅70.89 - 95.72
成交量12,416,150
平均成交量12,421,906
市值232.372B
Beta 值 (5 年,每月)0.37
市盈率 (最近 12 個月)16.77
每股盈利 (最近 12 個月)5.48
業績公佈日2022年7月28日
遠期股息及收益率2.76 (3.00%)
除息日2022年6月14日
1 年預測目標價97.61
  • HK MoneyClub

    準備在股市獲利的5項不會出錯投資

    “不會出錯”是一個嚴肅標準,但有幾家實力雄厚的公司確實做到了這句話意思。

  • InvestorPlace

    3 Dow Stocks to Buy for a Bear Market

    A new battle with inflation has thrown Dow stocks into a bear market. At last week’s low, the Dow Jones Industrial Index was down 19.8% from its January peak – close enough to trigger the bear market alarm bells for all but the strictest of market watchers. Besides, all other indexes have already sunk deep into bear country. With a volatile and treacherous environment now upon us, it’s worth asking which are the best Dow stocks to buy? Of course, the answer depends on what you’re looking for, so

  • Benzinga

    Merck/Seagen Potential Deal Talks Pick Up Speed: WSJ

    Merck & Co Inc (NYSE: MRK) is pushing forward with a potential deal for Seagen Inc (NASDAQ: SGEN), Wall Street Journal reported, citing people familiar with the matter. The Journal mentioned that the deal could be one of the largest takeovers of the year. The Wall Street Journal reported last week that Merck was in talks to buy Seagen, which would bolster the pharma giant's cancer-drug portfolio, but no agreement was imminent. Related: SVB Leerink's Pro-forma Analysis Of Speculated Merck/Seagen